Argyle Capital Management Inc. Abbott Laboratories Transaction History
Argyle Capital Management Inc.
- $248 Million
- Q3 2024
A detailed history of Argyle Capital Management Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Argyle Capital Management Inc. holds 3,850 shares of ABT stock, worth $439,785. This represents 0.18% of its overall portfolio holdings.
Number of Shares
3,850
Previous 3,715
3.63%
Holding current value
$439,785
Previous $386,000
13.47%
% of portfolio
0.18%
Previous 0.16%
Shares
10 transactions
Others Institutions Holding ABT
# of Institutions
3,186Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$19.2 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$15 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$8.76 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.51 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.09 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $200B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...